Morgan Stanley’s Akili Inc AKLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-1,000
Closed -$435 8153
2024
Q2
$435 Hold
1,000
﹤0.01% 7242
2024
Q1
$290 Sell
1,000
-1,500
-60% -$468 ﹤0.01% 7279
2023
Q4
$1.22K Buy
2,500
+1,250
+100% +$577 ﹤0.01% 7183
2023
Q3
$686 Sell
1,250
-1,500
-55% -$1.49K ﹤0.01% 7274
2023
Q2
$3.05K Hold
2,750
﹤0.01% 7098
2023
Q1
$4.4K Buy
2,750
+109
+4% +$170 ﹤0.01% 7082
2022
Q4
$2.96K Buy
+2,641
New +$4.65K ﹤0.01% 7273
2022
Q2
Sell
-2,200
Closed -$22K 8067
2022
Q1
$22K Sell
2,200
-4,500
-67% -$44.4K ﹤0.01% 7114
2021
Q4
$67K Buy
6,700
+2,600
+63% +$25.7K ﹤0.01% 6664
2021
Q3
$41K Buy
+4,100
New +$40.5K ﹤0.01% 6805

Morgan Stanley's AKLI Position: Q3 2024 in Review

Morgan Stanley sold out of Akili Inc (AKLI) in Q3 2024, closing a stake of 1,000 shares — an estimated $435 sold.

Morgan Stanley first reported a position in AKLI in Q3 2021 and held it in 10 quarters. The position peaked at $67K in Q4 2021. 0 funds tracked by Wall St. Rank hold AKLI as of Q3 2024.

  • Morgan Stanley reported no remaining Akili Inc position as of Q3 2024 after selling out during the quarter.
  • Morgan Stanley sold 1,000 Akili Inc shares in Q3 2024, an estimated $435.
  • Morgan Stanley first reported a position in Akili Inc in Q3 2021 and held it in 10 quarters.
  • Morgan Stanley's Akili Inc position peaked at $67K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Akili Inc as of Q3 2024.

Based on Morgan Stanley's 13F filing for Q3 2024, filed 14 Nov 2024.